Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals was a company that focused on developing therapies for inflammatory conditions. The company was dissolved in August 2024 following stockholder approval of a Plan of Dissolution. The remaining assets, primarily cash, are intended for distribution to stockholders after settling legal obligations, subject to court approval. Updates are to be posted on the company's website.
Offisielt Register
AI Kvalitetsanalyse
Tillitsscore Detaljer
Snarveier
🌟 Lignende Pålitelige Bedrifter
ACHIEVE LIFE SCIENCES, INC.
Achieve Life Sciences is a specialty pharmaceutical company focused on tackling the global nicotine dependence epidemic. Their key product, cytisinicline, is being developed as a treatment option for smoking cessation. Achieve's New Drug Application for cytisinicline has been accepted by the FDA, with a PDUFA date set for June 20, 2026, potentially offering the first new FDA-approved treatment in nearly 20 years.
Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals focuses on the development and commercialization of novel therapies to address unmet medical needs. Their key products include HETLIOZ® and Fanapt®. They aim to innovate in the service of people's pursuit of happiness.
NovaBay Pharmaceuticals, Inc.
We are a pharmaceutical company focused on scientifically created and clinically proven eyecare and skincare products. We also manufacture and sell NeutroPhase, a proprietary hypochlorous acid for the wound care market, used for cleansing wounds. Our product NeutroPhase is distributed in China by Pioneer Pharma (Hong Kong) Company Ltd.